These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hemochromatosis and iron-overload screening in a racially diverse population. Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P; N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186 [TBL] [Abstract][Full Text] [Related]
6. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study. Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827 [TBL] [Abstract][Full Text] [Related]
7. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis. Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943 [TBL] [Abstract][Full Text] [Related]
8. Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre. Ryan E; Ryan JD; Russell J; Coughlan B; Tjalsma H; Swinkels DW; Stewart S; Crowe JP Acta Haematol; 2015; 133(2):155-61. PubMed ID: 25277871 [TBL] [Abstract][Full Text] [Related]
9. Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Adams PC; Speechley M; Barton JC; McLaren CE; McLaren GD; Eckfeldt JH Hepatology; 2012 Jun; 55(6):1722-6. PubMed ID: 22183642 [TBL] [Abstract][Full Text] [Related]
10. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study. Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565 [TBL] [Abstract][Full Text] [Related]
11. Effects of C282Y, H63D, and S65C HFE gene mutations, diet, and life-style factors on iron status in a general Mediterranean population from Tarragona, Spain. Aranda N; Viteri FE; Montserrat C; Arija V Ann Hematol; 2010 Aug; 89(8):767-73. PubMed ID: 20107990 [TBL] [Abstract][Full Text] [Related]
12. HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L. Adams PC; McLaren CE; Speechley M; McLaren GD; Barton JC; Eckfeldt JH Can J Gastroenterol; 2013 Jul; 27(7):390-2. PubMed ID: 23862168 [TBL] [Abstract][Full Text] [Related]
13. Predicting C282Y homozygote genotype for hemochromatosis using serum ferritin and transferrin saturation values from 44,809 participants of the HEIRS study. Lim A; Speechley M; Adams PC Can J Gastroenterol Hepatol; 2014 Oct; 28(9):502-4. PubMed ID: 25314357 [TBL] [Abstract][Full Text] [Related]
14. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation. Velati C; Marlianici E; Rigamonti D; Barillari G; Chiavilli F; Fugiani P; Garozzo G; Lancieri M; Rinaldi S; Testa D; Sampietro M; Tavazzi D; Delbini P; Fargion S; Fiorelli G Hematol J; 2003; 4(6):436-40. PubMed ID: 14671617 [TBL] [Abstract][Full Text] [Related]
15. HFE mutations, iron deficiency and overload in 10,500 blood donors. Jackson HA; Carter K; Darke C; Guttridge MG; Ravine D; Hutton RD; Napier JA; Worwood M Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872 [TBL] [Abstract][Full Text] [Related]
16. Relationships of serum ferritin, transferrin saturation, and HFE mutations and self-reported diabetes in the Hemochromatosis and Iron Overload Screening (HEIRS) study. Acton RT; Barton JC; Passmore LV; Adams PC; Speechley MR; Dawkins FW; Sholinsky P; Reboussin DM; McLaren GD; Harris EL; Bent TC; Vogt TM; Castro O Diabetes Care; 2006 Sep; 29(9):2084-9. PubMed ID: 16936157 [TBL] [Abstract][Full Text] [Related]
17. Hemochromatosis mutations in the general population: iron overload progression rate. Andersen RV; Tybjaerg-Hansen A; Appleyard M; Birgens H; Nordestgaard BG Blood; 2004 Apr; 103(8):2914-9. PubMed ID: 15070663 [TBL] [Abstract][Full Text] [Related]
18. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC; Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211 [TBL] [Abstract][Full Text] [Related]
19. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study. Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH; Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828 [TBL] [Abstract][Full Text] [Related]
20. Diagnosis of hemochromatosis in family members of probands: a comparison of phenotyping and HFE genotyping. Barton JC; Rothenberg BE; Bertoli LF; Acton RT Genet Med; 1999; 1(3):89-93. PubMed ID: 11336458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]